David Ebsworth

David Ebsworth holds a doctorate from the University of Surrey. He is a consultant to the industry and is also currently active as chairman of the board of Wilex AG and Atani Ltd as well as a member of the board of Xention Ltd and Renovo Plc. David Ebsworth is a former president and general manager of the pharmaceutical business group of Bayer AG. He was previously also Chief Executive Officer and a member of the board of Oxford GlycoSciences Plc, and a former member of the board of Novuspharma S.p.A., Betapharm GmbH, Skyepharma Plc, Curagen Corp., A&D Pharma Holdings NV and Curacyte AG.